Name | Inolimomab |
---|
Description | Inolimomab is an anti-interleukin-2 receptor (IL-2R) α chain monoclonal antibody. Inolimomab improves the survival rate of patients in the early research of treating acute graft-versus-host disease (aGVHD)[1][2]. |
---|---|
Related Catalog | |
References |
No Any Chemical & Physical Properties |